Fulcrum Asset Management LLP Becton Dickinson & CO Transaction History

Fulcrum Asset Management LLP

  • $32.1 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024
SELL
$225.07 - $246.17 $455,766 - $498,494
-2,025 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$243.64 - $270.48 $252,654 - $280,487
-1,037 Reduced 33.87%
2,025 $504,000
Q3 2021

Oct 19, 2021
BUY
$232.72 - $256.47 $712,588 - $785,311
3,062 New
3,062 $720,000
Q2 2021

Jul 13, 2021
BUY
$232.65 - $254.58 $0 - $0
0 New
0 $717,000
Q2 2021

Jul 12, 2021
SELL
$232.65 - $254.58 $578,367 - $632,885
-2,486 Closed
0 $717,000
Q1 2021

Apr 21, 2021
BUY
$232.09 - $256.88 $576,975 - $638,603
2,486 New
2,486 $557,000

Others Institutions Holding BDX

# of Institutions
1,733
Shares Held
252M
Call Options Held
586K
Put Options Held
649K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Fulcrum Asset Management LLP Portfolio

Follow Fulcrum Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Asset Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email